Cleveland.com: Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

11/05/2024

CLEVELAND, Ohio — A biotech startup from North Carolina thinks Cleveland is where it will develop how to treat rare cancers with just three pills a month.

If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy for some types of hard-to-treat cancer, said CEO Dr. Gabi Hanna.

CLICK HERE to read the full story from Cleveland.com.

READ MORE

10/27/2025

Crain’s Cleveland Business: Notable Leaders in Health Care Technology 2025

Health care technology is rapidly transforming how we prevent, diagnose and treat disease, and Northeast Ohio is at the forefront of this evolution. Read Crain's full feature, which includes Lamassu Biotech CEO Dr. Gabi Hanna and Co-Founder Dr. Rabi Hanna.

READ THE ARTICLE
10/06/2025

Drug Discovery Online: Answering The Call To Develop Novel Drugs For Rare DiseasesDrug Discovery Online:

Faced with a serious diagnosis or an unexpected hospitalization, patients and their families are often left feeling like they’ve been hit with a gut punch. This insecurity is compounded when the diagnosis is some type of rare condition, such as...

READ THE ARTICLE
06/26/2025

Crain’s Cleveland Business: The U.S. Is Losing Its Biotech Edge

Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, and rising international competition.  If we do not act to strengthen...

READ THE ARTICLE